Back to LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA

REGN
Showing 8 of 22 quarters

Position history for LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA's holdings in REGENERON PHARMACEUTICALS

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA holds 72,430 shares of REGN (REGENERON PHARMACEUTICALS), worth $54.2M as of 2026-Q1. The position was decreased (-16.7% shares). REGN represents 0.5% of LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA's portfolio.

Current Value

$54.2M

Current Shares

72,430

Total Value Change

-$59.3M

Total Shares Change

-31,250

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
72,430
-16.7%
$54.2M0.5%$766.66
0
2025-Q4
Decreased
86,975
-5.2%
$67.1M0.6%$773.94
0
2025-Q3
Decreased
91,727
-8.2%
$52.8M0.5%$560.05
0
2025-Q2
Increased
99,913
+3.6%
$52.5M0.5%$519.56
36
2025-Q1
Decreased
96,473
-9.1%
$56.7M0.6%$634.66
0
2024-Q4
Decreased
106,091
-3.1%
$72.6M0.6%$698.71
0
2024-Q3
Increased
109,481
+5.6%
$101.7M0.9%$1,036.94
45
2024-Q2
Increased
103,680
+18.8%
$113.5M1.0%$1,045.23
56

Other major holders of REGN: VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used